In addition, both SNAT1 and SNAT2 were significantly elevated in serous carcinoma compared to endometrioid adenocarcinoma of the uterus (Supplementary Figure 1B and D). This evidence concerns the gene SLC38A2 and endometrioid adenocarcinoma.